FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jalid Sehouli

Research Profile

Disorders

Concepts & Ideas

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Paul Sabbatini; Giovanni Scambia; Simona Scartoni; Barbara Schmalfeldt; Jalid Sehouli; Luigi Selvaggi; Cecilia Simonelli; Jan B Vermorken; Pauline Wimberger; Tamas Pinter; Eric Pujade-Lauraine; Klaus H Baumann; Jonathan S Berek; Monica Bertolotti; Mariusz Bidzinski; Angela Capriati; Antonio Casado; David Cibula; Nicoletta Colombo; Karel Cwiertka; Jose Del Campo; Philipp Harter; Robert W Holloway; Christian Kurzeder; Andrew Li; Carlo Alberto Maggi; Andrea Martoni; Werner Meier; Jacobus Pfisterer
Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO--The MIMOSA Study.
Mani Nassir; Rolf Richter; Jalid Sehouli; Florin Stamatian; Radoslav Chekerov; Silvia Darb-Esfahani; Carsten Denkert; Christina Fotopoulou; Christina Hall; Mustafa Zelal Muallem; Elena Ioana Braicu
HE4 Tissue Expression in Borderline Ovarian Tumors: A Pilot Study by the Tumorbank Ovarian Cancer Network.
Sarah Zurmeyer; Jalid Sehouli; Elena Braicu; Christina Fotopoulou; Uwe Schlichting
Clostridium septicum Can Cause Distant Myonecrosis in Patients with Ovarian Cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jalid Sehouli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Paul Sabbatini; Giovanni Scambia; Simona Scartoni; Barbara Schmalfeldt; Jalid Sehouli; Luigi Selvaggi; Cecilia Simonelli; Jan B Vermorken; Pauline Wimberger; Tamas Pinter; Eric Pujade-Lauraine; Klaus H Baumann; Jonathan S Berek; Monica Bertolotti; Mariusz Bidzinski; Angela Capriati; Antonio Casado; David Cibula; Nicoletta Colombo; Karel Cwiertka; Jose Del Campo; Philipp Harter; Robert W Holloway; Christian Kurzeder; Andrew Li; Carlo Alberto Maggi; Andrea Martoni; Werner Meier; Jacobus Pfisterer
Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO--The MIMOSA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(12):1554-61.
2013: Mani Nassir; Rolf Richter; Jalid Sehouli; Florin Stamatian; Radoslav Chekerov; Silvia Darb-Esfahani; Carsten Denkert; Christina Fotopoulou; Christina Hall; Mustafa Zelal Muallem; Elena Ioana Braicu
HE4 Tissue Expression in Borderline Ovarian Tumors: A Pilot Study by the Tumorbank Ovarian Cancer Network.
Anticancer research 2013;33(4):1673-7.
2013: Sarah Zurmeyer; Jalid Sehouli; Elena Braicu; Christina Fotopoulou; Uwe Schlichting
Clostridium septicum Can Cause Distant Myonecrosis in Patients with Ovarian Cancer.
Anticancer research 2013;33(4):1585-9.
2013: Christina Fotopoulou; Murat Gultekin; Philipp Harter; Sanjeev Kumar; Dongli Liu; Angelo Maggioni; Sven Mahner; Michele Peiretti; Rolf Richter; Ali Ayhan; Ioana Braicu; David Cibula; Sean C Dowdy; Fabian Trillsch; Claes Trope; Rongyu Zang; Jalid Sehouli
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.
Annals of surgical oncology 2013;20(4):1348-54.
2013: Dietmar Pils; Jalid Sehouli; Dan Cacsire Castillo-Tong; Petr Vanhara; Michael Wittinger; Robert Zeillinger; Michaela Petz; Angela Alfanz; Mariam Anees; Veronika Auner; Elena Ioana Braicu; Andreas Gleiss; Alfred Gugerell; Peter Horak; michael krainer
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
Cancer 2013;119(5):946-54.
2013: Radoslav Chekerov; Sven Mahner; Christian Marth; Rolf Richter; Paul Speiser; Toon Van Gorp; Ignace Vergote; Linn Woelber; Robert Zeillinger; Ioana Braicu; Isabelle Cadron; Dan Cacsire Castillo-Tong; Jalid Sehouli
Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2013;23(2):268-75.
2013: Elena Ioana Braicu; H Butz; D Cacsire Castillo-Tong; R Chekerov; Nicole Concin; C Fotopoulou; C Hall; Sven Mahner; R Richter; Toon Van Gorp; I Vergote; Robert Zeillinger; Jalid Sehouli
Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study.
Gynecologic oncology 2013;128(2):245-51.
2013: A Feldheiser; C Fotopoulou; A Jones; V Pavlova; Jalid Sehouli; T Bonomo; Klaus-Dieter Wernecke; Claudia Spies
Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm.
British journal of anaesthesia 2013;110(2):231-40.
2013: Dirk Bauerschlag; Karen Bräutigam; Garret M Hampton; Maryla Krajewska; Nicolai Maass; Roland Moll; Alexander Mustea; John C Reed; Darius Salehin; Jalid Sehouli; Ivo Meinhold-Heerlein
Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary.
Journal of cancer research and clinical oncology 2013;139(2):347-55.
2013: Elena Frisch; Jörn Gröne; Elena Iona Braicu; Matthias Kaup; Johannes C Lauscher; Christian Schwedler; Jalid Sehouli; Rudolf Tauber; Matthias Zimmermann; Markus Berger; Véronique Blanchard
Endo-β-N-acetylglucosaminidase H de-N-glycosylation in a domestic microwave oven: application to biomarker discovery.
Analytical biochemistry 2013;433(1):65-9.
2013: C Fotopoulou; P Kosian; G Papanikolaou; K Pietzner; K Savvatis; Sven Christian Schmidt; I E Braicu; Jalid Sehouli
Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?
British journal of cancer 2013;108(1):32-8.
2013: Dietmar Pils; Eva Schuster; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Toon Van Gorp; Ignace Vergote; Andrea Wolf; Stefanie Aust; Ioana Braicu; Nicole Concin; Gudrun Hager; Georg Heinze; Maria Kohl; Sven Mahner; Eva Obermayr; Robert Zeillinger
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium.
BMC cancer 2013;13():178.
2013: Maike de Wit; Carsten Bokemeyer; Hans-Peter Lipp; Regine Mayer-Steinacker; Petra Ortner; Markus Ruhnke; Jalid Sehouli; Michael Untch; Karin Jordan
Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatment.
Onkologie 2013;36(3):127-35.
2013: Andreas Melmer; Jalid Sehouli; Ignace Vergote; Robert Zeillinger; Alain G Zeimet; Ioana Braicu; Isabelle Cadron; Dan Cacsire Castillo-Tong; Benjamin Dieplinger; Christoph F Ebenbichler; Linda Fineder; Barbara Kollerits; Claudia Lamina; Sven Mahner; Hans Dieplinger
Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortium.
Gynecologic oncology 2013;128(1):38-43.
2013: Eva Obermayr; Dietmar Pils; Jalid Sehouli; Paul Speiser; Toon Van Gorp; Ignace Vergote; Ioana Braicu; Dan Cacsire Castillo-Tong; Sven Mahner; Robert Zeillinger
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium.
Gynecologic oncology 2013;128(1):15-21.
2012: H Woopen; Elena Ioana Braicu; S Darb-Esfahani; K Pietzner; Jalid Sehouli; C Fotopoulou
Clinical experience of young patients with small cell ovarian carcinoma of the hypercalcemic type (OSCCHT).
European journal of obstetrics, gynecology, and reproductive biology 2012;165(2):313-7.
2012: H Woopen; S Darb-Esfahani; G Oskay-Oezcelik; K Pietzner; Jalid Sehouli
Extraperitoneal response to intraperitoneal immunotherapy with catumaxomab in a patient with cutaneous lymphangiosis carcinomatosa from ovarian cancer: a case report and review of the literature.
Medical oncology (Northwood, London, England) 2012;29(5):3416-20.
2012: Adak Pilger; Rolf Richter; Carmen Beteta; Christina Fotopoulou; Christine Klapp; Jalid Sehouli
Quality of life and sexuality of patients after treatment for gynaecological malignancies: results of a prospective study in 55 patients.
Anticancer research 2012;32(11):5045-9.
2012: Ulf P Neumann; Georgios Papanikolaou; Maximilian Schmeding; Elena Ioana Braicu; Christina Fotopoulou; Peter Neuhaus; Armin Thelen; Jalid Sehouli
Clinical outcome of patients with advanced ovarian cancer after resection of liver metastases.
Anticancer research 2012;32(10):4517-21.
2012: L C Hanker; P Harter; Sibylle Loibl; W Meier; J Pfisterer; E Pujade-Lauraine; I Ray-Coquard; Jalid Sehouli; N Burchardi; Andreas du Bois
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2605-12.
2012: Hrvoje Luketina; Ruzica-Rosalia Luketina; Adak Pilger; Christina Fotopoulou; Jalid Sehouli
Treatment decision-making processes in the systemic treatment of ovarian cancer: review of the scientific evidence.
Anticancer research 2012;32(9):4085-90.
2012: Rolf Richter; Harald Sommer; Oumar Camara; Radoslav Chekerov; Jens Einenkel; Hans-Joachim Hindenburg; Elke Keil; Guelten Oskay-Oezcelik; Adak Pilger; Jalid Sehouli
Health-related quality of life during sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: a multicenter phase ii study of the North Eastern German Society of Gynecological Oncology.
Anticancer research 2012;32(9):3969-76.
2012: K H Baumann; U Canzler; T Dewitz; Andreas du Bois; L C Hanker; Annette Hasenburg; P Hillemanns; F Hilpert; Christian Kurzeder; Werner Meier; J Rau; B Richter; Jalid Sehouli; Pauline Wimberger; Kerstin Wollschlaeger; Dirk Bauerschlag; Uwe Wagner
A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(9):2265-71.
2012: Jalid Sehouli; E Simon; H Leber; Werner Lichtenegger; C Oberhoff; C Olbrich; R Richter; I B Runnebaum; A Belau; U Blohmer; Dirk Boehmer; A du Bois; C Fotopoulou; K Friese; L C Hanker; Wolfgang Hartmann; G Heinrich; M D Keyver-Paik; R Kimmig; S Kuemmel
A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(9):2259-64.
2012: Frederik Marmé; Joachim Rom; Andreas Schneeweiss; Jalid Sehouli; Christof Sohn; Ignace Vergote; Robert Zeillinger; Sandra Bondong; Ioana Braicu; Dan Cacsire Castillo-Tong; Irmgard Ferschke; Thomas Hielscher; Sarah Hug; Cadron Isabella; Sven Mahner; Peter Altevogt
Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.
International journal of cancer. Journal international du cancer 2012;131(4):E586-91.
2012: S Darb-Esfahani; I Braicu; Manfred Dietel; F Fritzsche; Glen Kristiansen; Jalid Sehouli; Wilko Weichert; Carsten Denkert
Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma.
Virchows Archiv : an international journal of pathology 2012;461(2):109-16.
2012: Werner Meier; Jörn Rau; Barbara Richter; Barbara Schmalfeldt; Willibald Schröder; Anne Stähle; Pauline Wimberger; Kerstin Wollschlaeger; Klaus Baumann; Antje Belau; Alexander Burges; Ulrich Canzler; Andreas du Bois; Martina Gropp-Meier; Jens Huober; Rolf Kreienberg; Jalid Sehouli
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV.
Gynecologic oncology 2012;126(2):236-40.
2012: Sven Mahner; Susanne Markmann; Gülten Oskay-Özcelik; Birgit Ruhmland; Antje Belau; Stefan Fuxius; Elke Heidrich-Lorsbach; Thomas Heuser; Peter Klare; Heinz Kölbl; Harald Sommer; Jalid Sehouli
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis.
Journal of cancer research and clinical oncology 2012;138(8):1413-9.
2012: Dietmar Pils; Eva Schuster; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Ignace Vergote; Andrea Wolf; Stefanie Aust; Ioana Braicu; Isabelle Cadron; Gudrun Hager; Georg Heinze; Gerda Hofstetter; Maria Kohl; Sven Mahner; Robert Zeillinger
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
Cancer science 2012;103(7):1334-41.
2012: S Bondong; I Braicu; Isabelle Cadron; D C Castillo-Tong; Mina Fogel; T Hielscher; H Kiefel; Sven Mahner; D Pils; E Schuster; Jalid Sehouli; I Vergote; Robert Zeillinger; A G Zeimet; Peter Altevogt
Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(7):1795-802.
2012: Klaus Pietzner; Alexandra Schoberth; Michael Jäger; Marc Kuhberg; Horst Lindhofer; Gülten Oskay-Özcelik; Jalid Sehouli
First patient treated with a re-challenge of catumaxomab in recurrent malignant ascites: a case report.
Medical oncology (Northwood, London, England) 2012;29(2):1391-6.
2012: Joanna D Stewart; Berno Tanner; Herbert Waldmann; Mandy Eibisch; James K Ellis; Christian Hedberg; Roland Hergenroeder; Hector C Keun; Joerg Lambert; Chung-Ho Lau; Ekkehart Lausch; Michaela S Lesjak; Rosemarie Marchan; Jens Sagemueller; Juergen Schiller; Gerd Schmitz; Jalid Sehouli; Hagen Staude; Eric Steiner; Jan G Hengstler
Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(21):8155-60.
2012: Mustafa Zelal Muallem; Uwe Trefzer; Sule Yildiz; Ruza Arsenic; Jalid Sehouli
Vaginal fistula in a patient with relapsed ovarian cancer and amelanotic melanoma.
Anticancer research 2012;32(5):1737-42.
2012: Jason D Wright; Jalid Sehouli; Nicanor I Barrena Medel; Keiichi Fujiwara; Thomas J Herzog
Contemporary management of endometrial cancer.
Lancet 2012;379(9823):1352-60.
2012: Jalid Sehouli; Elena Ioana Braicu; Peter Neuhaus; G Papanikolaou; K Pietzner; C Fotopoulou
Feasibility of surgery after systemic treatment with the humanized recombinant antibody bevacizumab in heavily pretreated patients with advanced epithelial ovarian cancer.
Annals of surgical oncology 2012;19(4):1326-33.
2012: Stephan Polterauer; Ioana Braicu; Isabelle Cadron; Dan Cacsire Castillo-Tong; Radoslav Chekerov; Nicole Concin; Sven Mahner; Toon Van Gorp; Ignace Vergote; Linn Woelber; Robert Zeillinger; Jalid Sehouli
Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012;22(3):380-5.
2012: Gerda Hofstetter; Elisabeth Müller-Holzner; Dan Cacsire Castillo-Tong; Hanno Ulmer; Jalid Sehouli; Robert Zeillinger; Daniel Reimer; Elena I Braicu; Martina Chamson; Eva-Maria Bauer; Andrea Wolf; Astrid Berger; Eva Schuster; Nicole Concin
MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer.
Oncology reports 2012;27(3):673-7.
2012: Elena Ioana Braicu; Werner Lichtenegger; Klaus Pietzner; Rolf Richter; Jalid Sehouli; Christina Fotopoulou
Primary versus secondary cytoreduction for epithelial ovarian cancer: a paired analysis of tumour pattern and surgical outcome.
European journal of cancer (Oxford, England : 1990) 2012;48(5):687-94.
2012: Jalid Sehouli; V Alfaro; A González-Martín
Trabectedin plus pegylated liposomal doxorubicin in the treatment of patients with partially platinum-sensitive ovarian cancer: current evidence and future perspectives.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(3):556-62.
2012: Andreas du Bois; Philipp Harter; Felix Hilpert; Christian Marth; Jacobus Pfisterer; Alain G Zeimet; Jalid Sehouli
Neoadjuvant chemotherapy cannot be regarded as adequate routine therapy strategy of advanced ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012;22(2):182-5.
2012: Jalid Sehouli; Cezary Szczylik; Annamaria Zimmermann; Ana Maria Alvarez; Thomas Bauknecht; Prafull Ghatage; Katherine Y Look; Shokoufeh Manouchehrpour; Gultan Oskay-Öezcelik
A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer.
Gynecologic oncology 2012;124(2):205-9.
2012: WJ Tian; Claes G Tropé; Yan Xing; Rongyu Zang; Rong Jiang; Hans-Gerd Meerpohl; Halldis Oksefjell; Catherine A Rabbitt; Jalid Sehouli; Ali Ayhan; Jonathan S Berek; Elena Ioana Braicu; Georg-Peter Breitbach; Dennis S Chi; Gennaro Cormio; Andreas du Bois; Christina Fotopoulou; Philipp Harter
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection.
Annals of surgical oncology 2012;19(2):597-604.
2012: Nuran Bektas Serce; Sonja von Serényi; Matthias W Beckmann; Andreas Boesl; Arno Dimmler; Peter A Fasching; Arndt Hartmann; Irina Klaman; Ruth Knuechel; Erik Noetzel; Michael F Press; Jalid Sehouli; Edgar Dahl
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.
BMC cancer 2012;12():597.
2012: Stefanie Aust; Anna Bachmayr-Heyda; Radoslav Chekerov; Silvia Darb-Esfahani; Carsten Denkert; Reinhard Horvat; Sven Mahner; Petra Pateisky; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Toon Van Gorp; Ignace Vergote; Robert Zeillinger; Dietmar Pils
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.
Molecular cancer 2012;11():69.
2012: Christina Fotopoulou; Ioana Braicu; Jalid Sehouli
Fertility-sparing surgery in early epithelial ovarian cancer: a viable option?
Obstetrics and gynecology international 2012;2012():238061.
2011: Timothy J Perren; Christian Kurzeder; Frédéric Selle; Rainer Kimmig; Sharadah Essapen; Marie Plante; Gunnar Kristensen; Jalid Sehouli; Andrés Cervantes; Fiona Collinson; Mahesh K B Parmar; Arto Leminen; Wendi Qian; Alain Lortholary; Philip Beale; Eric Pujade-Lauraine; Andreas du Bois; Ann Marie Swart; Mansoor R Mirza; Charlie Gourley; Anne Stähle; Jacobus Pfisterer; Dan Stark; Amit M Oza; Jonathan A Ledermann; Mark S Carey
A phase 3 trial of bevacizumab in ovarian cancer.
The New England journal of medicine 2011;365(26):2484-96.
2011: Elena Ioana Braicu; Carsten Denkert; K Pietzner; R Richter; Jalid Sehouli; C Fotopoulou
Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers.
British journal of cancer 2011;105(12):1818-24.
2011: Gerda Hofstetter; S Mahner; Christian Marth; Eva Schuster; Jalid Sehouli; P Speiser; Hanno Ulmer; Ignace Vergote; A Wolf; Robert Zeillinger; Alain G Zeimet; A Berger; E I Braicu; I Cadron; G Hager; Nicole Concin
Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.
British journal of cancer 2011;105(10):1593-9.
2011: Bruno V Sinn; Ralph M Wirtz; Manfred Dietel; Jalid Sehouli; Jan Budczies; Radoslav Chekerov; Silvia Darb-Esfahani; Carsten Denkert
Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue.
Histopathology 2011;59(5):918-27.
2011: Jens-Uwe Blohmer; Dirk Boehmer; Volker Budach; Dirk Elling; Axel Hinke; Rainer Kimmig; Martin Kolben; Sherko Kümmel; Werner Lichtenegger; Volker Möbus; Stefan Paepke; Karl U Petry; Jalid Sehouli; Christoph Thomssen; Gunter von Minckwitz; Florian Würschmidt; Peter Schmid
Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin Alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(28):3791-7.
2011: K Baumann; N Burchardi; Andreas du Bois; Jens Huober; Christian Kurzeder; Sibylle Loibl; H J Lück; Jacobus Pfisterer; Barbara Schmalfeldt; Jalid Sehouli; I Vergote; Pauline Wimberger; U Wagner
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group.
Gynecologic oncology 2011;123(1):27-32.
2011: Rongyu Zang; A Ayhan; Elena Ioana Braicu; D S Chi; G Cormio; A du Bois; C Fotopoulou; P Harter; R Jiang; H Oksefjell; J Pfisterer; C A Rabbitt; Jalid Sehouli; WJ Tian; C G Tropé; K M Wollschlaeger; Y Xing; J S Berek
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.
British journal of cancer 2011;105(7):890-6.
2011: Christina Fotopoulou; Marc Kuhberg; Werner Lichtenegger; Rolf Richter; Joerg Schefold; Elena Ioana Braicu; Aarne Feldheiser; Jalid Sehouli
Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking.
Annals of surgical oncology 2011;18(9):2629-37.
2011: Klaus Pietzner; Rolf Richter; Radoslav Chekerov; Edibe Erol; Werner Lichtenegger; Gülten Oskay-Özcelik; Jalid Sehouli
Bevacizumab in heavily pre-treated and platinum resistant ovarian cancer: a retrospective study of the North-Eastern German Society of Gynaecologic Oncology (NOGGO) Ovarian Cancer Study Group.
Anticancer research 2011;31(8):2679-82.
2011: Klaus Pietzner; Rosa Bianca Schmuck; Chie Hee Cho; Christina Fotopoulou; Johanna Gellermann; Fakher Ismaeel; Michael Kalden; Jalid Sehouli
Long term combination treatment with bevacizumab, pegylated liposomal doxorubicin and regional abdominal hyperthermia in platinum refractory ovarian cancer: a case report and review of the literature.
Anticancer research 2011;31(8):2675-7.
2011: J K Schroeder; Jalid Sehouli; J Hector; S Kuemmel; K Pietzner; R Chekerov
Optimizing the clinical management of gynecological and breast cancer via online tumor conferences.
Anticancer research 2011;31(8):2669-73.
2011: R Chekerov; Andreas Ebert; C Herbstreit; A Jagota; K D Johannsmeyer; C Kronenberger; J Potenberg; Rolf Richter; J P Scharf; S Braun; U Ulrich; Jalid Sehouli
First evaluation of the Joint Clinical Registries of the Coordinating Tumor Center of Berlin.
Anticancer research 2011;31(8):2657-60.
2011: Solveig Landt; Werner Lichtenegger; Konstanze Mordelt; Ilka Schwidde; Jalid Sehouli; Frank Stöblen; Jana Barinoff; Susanne Korlach; Sherko Kümmel
Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer.
Anticancer research 2011;31(8):2651-5.
2011: Solveig Landt; Werner Lichtenegger; Cora Reuter; Jalid Sehouli; Frank Stöblen; Marc Thill; Jana Barinoff; Jens-Uwe Blohmer; Harald Heidecke; Till Heusner; Susanne Korlach; Sherko Kümmel
The utility of an in vitro angiogenesis score for prognosis assessment in patients with cervical cancer.
Anticancer research 2011;31(8):2645-9.
2011: Christina Fotopoulou; Gerhard Fusch; Rene Pschowski; Petra Reinke; Elena Ioana Braicu; Grazyna Domanska; Jalid Sehouli; Stephan von Haehling; Joerg Schefold
Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer.
Anticancer research 2011;31(8):2629-35.
2011: Solveig Landt; Cora Reuter; Ilka Schwidde; Jalid Sehouli; Marc Thill; Jana Barinoff; Harald Heidecke; Susanne Korlach; Sherko Kümmel
In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancer.
Anticancer research 2011;31(8):2609-15.
2011: Georgios Papanikolaou; Klaus Pietzner; Sven Christian Schmidt; Ioana Braicu; Radoslav Chekerov; Christina Fotopoulou; Jalid Sehouli
First surgical experience of intraperitoneal treatment with the trifunctional antibody catumaxomab (anti-EpCam x anti-CD3) for epithelial ovarian cancer.
Anticancer research 2011;31(8):2603-8.
2011: Federico Collettini; Timm Denecke; Ioana Elena Braicu; Bernd Hamm; Alexander Poellinger; Dirk Schnapauff; Jalid Sehouli; Peter Wust; Bernhard Gebauer
CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience.
Anticancer research 2011;31(8):2597-602.
2011: Solveig Landt; Werner Lichtenegger; Peter Schmid; Jalid Sehouli; Frank Stöblen; Michael Wehling; Jens-Uwe Blohmer; Harald Heidecke; Sophia Jeschke; Susanne Korlach; Sherko Kümmel
Prognostic significance of angiogenic factors in uterine cervical cancer.
Anticancer research 2011;31(8):2589-95.
2011: Blanca Gil-Ibáñez; Werner Lichtenegger; Peter Neuhaus; Gulten Oskay-Özcelik; Rolf Richter; Jalid Sehouli; Elena Ioana Braicu; Christina Fotopoulou
Predictive factors in relapsed ovarian cancer for complete tumor resection.
Anticancer research 2011;31(8):2583-7.
2011: Frank Stöblen; Jens-Uwe Blohmer; Rami Ishaq; Solveig Landt; Mahdi Rezai; Jalid Sehouli; Per Skaane; Ruth Stelkens-Gebhardt; Sherko Kümmel
High-frequency breast ultrasound for the detection of microcalcifications and associated masses in BI-RADS 4a patients.
Anticancer research 2011;31(8):2575-81.
2011: Frank Stöblen; Solveig Landt; Mahdi Rezai; Jalid Sehouli; Ruth Stelkens-Gebhardt; Sherko Kümmel
First evaluation of the diagnostic accuracy of an automated 3D ultrasound system in a breast screening setting.
Anticancer research 2011;31(8):2569-74.
2011: Michael Friedlander; Ros Glasspool; Antonio Gonzalez-Martin; Philipp Harter; Dionysis Katsaros; Jae Won Kim; Henry Kitchener; Brigitte Miller; Sandro Pignata; Diane Provencher; Eric Pujade-Lauraine; Lawrence Rubinstein; Jalid Sehouli; Gavin C E Stuart; Anna Tinker; Edward Trimble; Ignace Vergote; Alain Zeimet; David Alberts; Mostafa Atri; Elisabeth Avall-Lundqvist; Monica Bacon; Philip Beale; Rudd Bekkers; Mark Brady; Paula Calvert; Lawrence Copeland
Clinical trials in recurrent ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(4):771-5.
2011: Nelofer Syed; Peter Szlosarek; Sarah P Blagden; Helen M Coley; Eleftheria Hatzimichael; Dominique Koensgen; David P Lovell; Iain McNeish; Alexander Mustea; Peter Schmid; Jalid Sehouli; Tim Crook
Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.
Cancer research 2011;71(9):3317-27.
2011: Peter Richard Steinhagen; Jalid Sehouli
The involvement of retroperitoneal lymph nodes in primary serous-papillary peritoneal carcinoma. a systematic review of the literature.
Anticancer research 2011;31(4):1387-94.
2011: Ann-Christin Buckendahl; Jan Budczies; Oliver Fiehn; Silvia Darb-Esfahani; Tobias Kind; Aurelia Noske; Wilko Weichert; Jalid Sehouli; Elena Braicu; Manfred Dietel; Carsten Denkert
Prognostic impact of AMP-activated protein kinase expression in ovarian carcinoma: correlation of protein expression and GC/TOF-MS-based metabolomics.
Oncology reports 2011;25(4):1005-12.
2011: Philipp Harter; Jalid Sehouli; Alexander Reuss; Annette Hasenburg; Giovanni Scambia; David Cibula; Sven Mahner; Ignace Vergote; Alexander Reinthaller; Alexander Burges; Lars Hanker; Martin Pölcher; Christian Kurzeder; Ulrich Canzler; Karl Ulrich Petry; Andreas Obermair; Edgar Petru; Barbara Schmalfeldt; Domenica Lorusso; Andreas du Bois
Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(2):289-95.
2011: Jalid Sehouli; Christoph Loddenkemper; Tatjana Cornu; Tim Schwachula; Ulrich Hoffmüller; Andreas Grützkau; Philipp Lohneis; Thorsten Dickhaus; Jörn Gröne; Martin Kruschewski; Alexander Mustea; Ivana Turbachova; Udo Baron; Sven Olek
Epigenetic quantification of tumor-infiltrating T-lymphocytes.
Epigenetics : official journal of the DNA Methylation Society 2011;6(2):236-46.
2011: Jalid Sehouli; Dirk Stengel; Philipp Harter; Christian Kurzeder; Antje Belau; Thomas Bogenrieder; Susanne Markmann; Sven Mahner; Lothar Mueller; Ralf Lorenz; Andreas Nugent; Jochen Wilke; Andreas Kuznik; Gabriele Doering; Arthur Wischnik; Harald Sommer; Hans-Gerd Meerpohl; Willibald Schroeder; Werner Lichtenegger; Guelten Oskay-Oezcelik
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(2):242-8.
2011: Aurelia Noske; Michael Schwabe; Jalid Sehouli; Wilko Weichert; Elena Ioana Braicu; Ann-Christin Buckendahl; Jan Budczies; Silvia Darb-Esfahani; Manfred Dietel; Carsten Denkert
An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.
BMC cancer 2011;11():294.
2011: Christina Fotopoulou; Rolf Richter; Ioana Elena Braicu; Sven Christian Schmidt; Peter Neuhaus; Werner Lichtenegger; Jalid Sehouli
Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer.
Annals of surgical oncology 2011;18(1):49-57.
2010: Jessika Wynendaele; Anja Böhnke; Eleonora Leucci; Søren Jensby Nielsen; Irina Lambertz; Stefanie Hammer; Nadja Sbrzesny; Dana Kubitza; Anja Wolf; Elise Gradhand; Katharina Balschun; Ioana Braicu; Jalid Sehouli; Silvia Darb-Esfahani; Carsten Denkert; Christoph Thomssen; Steffen Hauptmann; Anders Lund; Jean-Christophe Marine; Frank Bartel
An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
Cancer research 2010;70(23):9641-9.
2010: Christina Fotopoulou; Marios Bugariu; Elena Ioana Braicu; Werner Lichtenegger; Jalid Sehouli
What are the individual perceptions of patients with borderline tumours of the ovary in regard to pathogenesis and prognosis? A structured survey on 60 women.
Journal of psychosomatic obstetrics and gynaecology 2010;31(4):265-72.
2010: C Fotopoulou; R Richter; Elena Ioana Braicu; Sven Christian Schmidt; Werner Lichtenegger; Jalid Sehouli
Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2010;36(12):1202-10.
2010: Jalid Sehouli; Konstantinos Savvatis; Elena Ioana Braicu; Sven Christian Schmidt; Werner Lichtenegger; Christina Fotopoulou
Primary versus interval debulking surgery in advanced ovarian cancer: results from a systematic single-center analysis.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010;20(8):1331-40.
2010: Jalid Sehouli; R Richter; Elena Ioana Braicu; Kai J Bühling; Marcus Bahra; Peter Neuhaus; Werner Lichtenegger; Christina Fotopoulou
Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.
Journal of surgical oncology 2010;102(6):656-62.
2010: C Fotopoulou; K Savvatis; Elena Ioana Braicu; V Brink-Spalink; S Darb-Esfahani; Werner Lichtenegger; Jalid Sehouli
Adult granulosa cell tumors of the ovary: tumor dissemination pattern at primary and recurrent situation, surgical outcome.
Gynecologic oncology 2010;119(2):285-90.
2010: Christina Fotopoulou; Nicole Gehrmann; Jalid Sehouli; Werner Lichtenegger
Reconstructive surgical management of cryptomenorrhea because of complex uterovaginal malformations with duplicate uterus and complete vaginal agenesis.
Fertility and sterility 2010;94(6):2329.e13-6.
2010: Jalid Sehouli; K Pietzner; P Harter; K Münstedt; Sven Mahner; A Hasenburg; Oumar Camara; P Wimberger; Dirk Boehmer; K J Buehling; R Richter; K El Khalfaoui; G Oskay-Ozcelik
Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(11):2201-5.
2010: Jalid Sehouli; G Oskay-Ozcelik
Use of paclitaxel for advanced ovarian cancer in clinical practice: analysis of 541 patients. Results from a German multi-centre observational study.
Anticancer research 2010;30(10):4245-50.
2010: Jalid Sehouli; Oumar Camara; Sven Mahner; Thomas Bauknecht; Werner Lichtenegger; Ingo Runnebaum; Katherine Look; Fritz Jaenicke; Guelten Oskay-Oezcelik
A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer.
Cancer chemotherapy and pharmacology 2010;66(5):861-8.
2010: Andreas du Bois; Jørn Herrstedt; Anne-Claire Hardy-Bessard; Hans-Helge Müller; Philipp Harter; Gunnar Kristensen; Florence Joly; Jens Huober; Elisabeth Avall-Lundqvist; Béatrice Weber; Christian Kurzeder; Svetislav Jelic; Eric Pujade-Lauraine; Alexander Burges; Jacobus Pfisterer; Martina Gropp; Anne Staehle; Pauline Wimberger; Christian Jackisch; Jalid Sehouli
Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4162-9.
2010: Dominique Koensgen; Guelten Oskay-Oezcelik; Ioanna Katsares; Ulla Walle; Christine Klapp; Alexander Mustea; Dirk Stengel; Franz Porzsolt; Werner Lichtenegger; Jalid Sehouli
Development of the Berlin Symptom Checklist Ovary (BSCL-O) for the measurement of quality of life of patients with primary and recurrent ovarian cancer: results of a phase I and II study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2010;18(8):931-42.
2010: Eric Pujade-Lauraine; Uwe Wagner; Elisabeth Aavall-Lundqvist; Val Gebski; Mark Heywood; Paul A Vasey; Birgit Volgger; Ignace Vergote; Sandro Pignata; Annamaria Ferrero; Jalid Sehouli; Alain Lortholary; Gunnar Kristensen; Christian Jackisch; Florence Joly; Chris Brown; Nathalie Le Fur; Andreas du Bois
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3323-9.
2010: R B Schmuck; K Pietzner; Ann-Christin Buckendahl; J Schönlebe; Jalid Sehouli
Cervical manifestation of a borderline type ovarian cancer with pseudomyxoma peritonei - a case report.
Anticancer research 2010;30(7):2991-4.
2010: Dominique Koensgen; Cornelia Freitag; Irina Klaman; Edgar Dahl; Alexander Mustea; Radoslav Chekerov; Ioana Braicu; Werner Lichtenegger; Jalid Sehouli
Expression and localization of e-cadherin in epithelial ovarian cancer.
Anticancer research 2010;30(7):2525-30.
2010: Irina Nazarenko; Marcel Jenny; Jana Keil; Cornelia Gieseler; Karen Weisshaupt; Jalid Sehouli; Stefan Legewie; Lena Herbst; Wilko Weichert; Silvia Darb-Esfahani; Manfred Dietel; Reinhold Schäfer; Florian Ueberall; Christine Sers
Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer.
Molecular cancer research : MCR 2010;8(6):919-34.
2010: Christina Fotopoulou; Jalid Sehouli; Nicole Gehrmann; Ines Schoenborn; Werner Lichtenegger
Functional and anatomic results of amnion vaginoplasty in young women with Mayer-Rokitansky-Küster-Hauser syndrome.
Fertility and sterility 2010;94(1):317-23.
2010: Jalid Sehouli; Guelten Oskay-Oezcelik; Klaus Pietzner; Frank Chen; Alexandra Coumbos; Silvia Darb-Esfahani; Beatrix Schuback; Georg Heinrich; Christel Kronenberger; Michael Lorsbach; Werner Lichtenegger; Radoslav Chekerov
Clinical management of borderline tumours of the ovary - experience from the "Berlin online tumour conference for gynaecological malignancies".
Anticancer research 2010;30(5):1701-6.
2010: Silvia Darb-Esfahani; Bruno V Sinn; Wilko Weichert; Jan Budczies; Annika Lehmann; Aurelia Noske; Ann-Christin Buckendahl; Berit-Maria Müller; Jalid Sehouli; Dominique Koensgen; Balázs Györffy; Manfred Dietel; Carsten Denkert
Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.
Histopathology 2010;56(6):727-39.
2010: Christina Fotopoulou; Ulf Neumann; Robert Kraetschell; Joerg C Schefold; H Weidemann; Werner Lichtenegger; Jalid Sehouli
Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
Journal of surgical oncology 2010;101(6):507-12.
2010: Dietmar Pils; Michael Wittinger; Michaela Petz; Alfred Gugerell; Wolfgang Gregor; Angela Alfanz; Reinhard Horvat; Elena Ioana Braicu; Jalid Sehouli; Robert Zeillinger; Wolfgang Mikulits; michael krainer
BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-beta treatment.
Gynecologic oncology 2010;117(2):189-97.
2010: Veronika Auner; Jalid Sehouli; Gülten Oskay-Oezcelik; Reinhard Horvat; Paul Speiser; Robert Zeillinger
ABC transporter gene expression in benign and malignant ovarian tissue.
Gynecologic oncology 2010;117(2):198-201.
2010: A K Luttkus; C Fotopoulou; Jalid Sehouli; J Stupin; J W Dudenhausen
Technical performance of lactate biosensors and a test-strip device during labour.
Zeitschrift für Geburtshilfe und Neonatologie 2010;214(2):62-7.
2010: Ignace Vergote; Eric Pujade-Lauraine; Sandro Pignata; Gunnar Kristensen; Jonathan Ledermann; Antonio Casado; Jalid Sehouli; Mansoor Raza Mirza; Roldano Fossati; Christian Marth; Carine Creutzberg; Jose Del Campo; Nadeem Siddiqui; Paula Calvert; Aris Bamias; Gokhan Tulunay; Ate G J van der Zee; Andreas du Bois
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010;20(3):476-8.
2010: Christina Fotopoulou; Konstantinos Savvatis; Robert Kraetschell; Joerg C Schefold; Werner Lichtenegger; Jalid Sehouli
Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
European journal of obstetrics, gynecology, and reproductive biology 2010;149(2):199-203.
2010: Jalid Sehouli; A Goertz; T Steinle; R Dubois; C Plesnila-Frank; A Lalla; G von Minckwitz
[Pegfilgrastim vs filgrastim in primary prophylaxis of febrile neutropenia in patients with breast cancer after chemotherapy: a cost-effectiveness analysis for Germany].
Deutsche medizinische Wochenschrift (1946) 2010;135(9):385-9.
2010: G Oskay-Ozcelik; R Chekerov; Harald Sommer; E Keil; J Einenkel; Jacobus Pfisterer; C Lorenz-Schlüter; Werner Lichtenegger; Oumar Camara; Jalid Sehouli
Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: results of a multicenter phase II study of the northeastern German society of gynecological oncology.
Gynecologic oncology 2010;116(3):317-22.
2010: Solveig Landt; Sophia Jeschke; Angela Koeninger; Anke Thomas; Till Heusner; Susanne Korlach; Kurt Ulm; Peter Schmidt; Jens-Uwe Blohmer; Werner Lichtenegger; Jalid Sehouli; Sherko Kuemmel
Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer.
Anticancer research 2010;30(2):375-81.
2010: Areeg Faggad; Jan Budczies; Oleg Tchernitsa; Silvia Darb-Esfahani; Jalid Sehouli; Berit-Maria Müller; Ralph Wirtz; Radoslav Chekerov; Wilko Weichert; Brigitte Sinn; Christin Mucha; Nasr E Elwali; Reinhold Schäfer; Manfred Dietel; Carsten Denkert
Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
The Journal of pathology 2010;220(3):382-91.
2010: M Markman; Jalid Sehouli; Charles F Levenback; Dennis S Chi
Epithelial ovarian cancer: focus on targeted therapy.
Journal of oncology 2010;2010():171425.
2010: Eva Obermayr; Fatima Sanchez Cabo; Muy-Kheng M Tea; Christian F Singer; michael krainer; Michael B Fischer; Jalid Sehouli; Alexander Reinthaller; Reinhard Horvat; Georg Heinze; Dan Cacsire Castillo-Tong; Robert Zeillinger
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
BMC cancer 2010;10():666.
2010: C Fotopoulou; Ulf Neumann; R Kraetschell; Werner Lichtenegger; Jalid Sehouli
External iliac artery ligation due to late postoperative rupture after radical lymphadenectomy for advanced ovarian cancer--two case reports.
European journal of gynaecological oncology 2010;31(2):198-200.
2010: Christina Fotopoulou; Robert Kraetschell; Johanna Gellermann; Peter Wust; Werner Lichtenegger; Chie Hee Cho; Jalid Sehouli
Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2010;26(2):118-26.
2010: Christina Fotopoulou; Konstantinos Savvatis; Elisabeth Steinhagen-Thiessen; Marcus Bahra; Werner Lichtenegger; Jalid Sehouli
Primary radical surgery in elderly patients with epithelial ovarian cancer: analysis of surgical outcome and long-term survival.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010;20(1):34-40.
2009: Christina Fotopoulou; Guido Schumacher; Joerg C Schefold; Carsten Denkert; Werner Lichtenegger; Jalid Sehouli
Systematic evaluation of the intraoperative tumor pattern in patients with borderline tumor of the ovary.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(9):1550-5.
2009: Ignace Vergote; Frederic Amant; Gülten Oskay-Oezcelik; Luna Musib; Anne-Laure Michel; Christelle Darstein; Marek Kania; Thomas Bauknecht; Jalid Sehouli
Carboplatin and paclitaxel in combination with oral enzastaurin in advanced ovarian or primary peritoneal cancer: results from a safety lead-in study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(9):1505-10.
2009: Bruno V Sinn; Silvia Darb-Esfahani; Ralph M Wirtz; Areeg Faggad; Wilko Weichert; Ann-Christin Buckendahl; Aurelia Noske; Berit-Maria Müller; Jan Budczies; Jalid Sehouli; Elena I Braicu; Manfred Dietel; Carsten Denkert
Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue.
Virchows Archiv : an international journal of pathology 2009;455(6):461-7.
2009: Claudio Zamagni; Ralph M Wirtz; Pierandrea De Iaco; Marta Rosati; Elke Veltrup; Federica Rosati; Elisa Capizzi; Nicoletta Cacciari; Carlo Alboni; Alessandra Bernardi; Francesco Massari; Sara Quercia; Antonia D'Errico-Grigioni; Manfred Dietel; Jalid Sehouli; Carsten Denkert; Andrea Martoni
Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies.
Endocrine-related cancer 2009;16(4):1241-9.
2009: Silvia Darb-Esfahani; Ralph M Wirtz; Bruno V Sinn; Jan Budczies; Aurelia Noske; Wilko Weichert; Areeg Faggad; Susanne Scharff; Jalid Sehouli; Guelten Oskay-Ozcelik; Claudio Zamagni; Pierandrea De Iaco; Andrea Martoni; Manfred Dietel; Carsten Denkert
Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue.
Endocrine-related cancer 2009;16(4):1229-39.
2009: Radoslav Chekerov; Dominique Koensgen; Irina Klaman; André Rosenthal; Guelten Oskay-Oezcelik; Alexander Mustea; Werner Lightenegger; Edgar Dahl; Jalid Sehouli
Tumor- and stromal cell-specific expression of topoisomerase IIα and HER-2/neu in primary and recurrent ovarian cancer: Results of a prospective study.
Molecular medicine reports 2009;2(6):1011-6.
2009: C Fotopoulou; A Karavas; R Trappe; R Chekerov; W Lichtenegger; Jalid Sehouli
Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO).
Thrombosis research 2009;124(5):531-5.
2009: Linda J Nicholson; Paul R Smith; Louise Hiller; Peter W Szlosarek; Christopher Kimberley; Jalid Sehouli; Dominique Koensgen; Alexander Mustea; Peter Schmid; Tim Crook
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
International journal of cancer. Journal international du cancer 2009;125(6):1454-63.
2009: Hannah Woopen; Jalid Sehouli
Current and future options in the treatment of malignant ascites in ovarian cancer.
Anticancer research 2009;29(8):3353-9.
2009: Jalid Sehouli; Oumar Camara; Mathias Schmidt; Sven Mahner; G Seipelt; B Otremba; Barbara Schmalfeldt; H Tesch; C Lorenz-Schlüter; G Oskay-Ozcelik
Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational study.
Cancer chemotherapy and pharmacology 2009;64(3):585-91.
2009: Oumar Camara; Jalid Sehouli
Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.
Anticancer research 2009;29(7):2837-43.
2009: G Oskay-Ozcelik; Jalid Sehouli
Pros and cons for systemic therapy in recurrent ovarian cancer.
Anticancer research 2009;29(7):2831-6.
2009: Sven Mahner; Linn Woelber; Sabine Jung; Christine Zu Eulenburg; Maike Ihnen; Jörg Schwarz; Jalid Sehouli; Fritz Jaenicke
Prognostic significance of CA-125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreduction.
Anticancer research 2009;29(7):2817-21.
2009: Christina Fotopoulou; Konstantinos Savvatis; Guido Schumacher; Werner Lichtenegger; Jalid Sehouli
Surgical outcome and survival analysis of young patients with primary epithelial ovarian cancer.
Anticancer research 2009;29(7):2809-15.
2009: Sascha Santosh Chopra; Sven Christian Schmidt; Christina Fotopoulou; Jalid Sehouli; Guido Schumacher
Evidence-based perioperative management: strategic shifts in times of fast track surgery.
Anticancer research 2009;29(7):2799-802.
2009: Klaus Pietzner; Guelten Oskay-Oezcelik; Khalid El Khalfaoui; Dirk Boehmer; Werner Lichtenegger; Jalid Sehouli
Brain metastases from epithelial ovarian cancer: overview and optimal management.
Anticancer research 2009;29(7):2793-8.
2009: Sascha Keller; Anne-Kathleen König; Frederik Marmé; Steffen Runz; Silke Wolterink; Dominique Koensgen; Alexander Mustea; Jalid Sehouli; Peter Altevogt
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
Cancer letters 2009;278(1):73-81.
2009: Alexandra Coumbos; Jalid Sehouli; R Chekerov; D Schaedel; G Oskay-Oezcelik; Werner Lichtenegger; W Kuehn
Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany.
British journal of cancer 2009;100(11):1731-8.
2009: A Martschick; Jalid Sehouli; Alexa Patzelt; Heike Richter; Ute Jacobi; G Oskay-Ozcelik; Wolfram Sterry; Jürgen Lademann
The pathogenetic mechanism of anthracycline-induced palmar-plantar erythrodysesthesia.
Anticancer research 2009;29(6):2307-13.
2009: Jalid Sehouli; Filiz Senyuva; Christina Fotopoulou; Ulf Neumann; Carsten Denkert; Lichtenegger Werner; Oskay-Ozcelik Gülten
Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer.
Journal of surgical oncology 2009;99(7):424-7.
2009: Carsten Denkert; Jan Budczies; Silvia Darb-Esfahani; Balázs Györffy; Jalid Sehouli; Dominique Könsgen; Robert Zeillinger; Wilko Weichert; Aurelia Noske; Ann-Christin Buckendahl; Berit M Müller; Manfred Dietel; Hermann Lage
A prognostic gene expression index in ovarian cancer - validation across different independent data sets.
The Journal of pathology 2009;218(2):273-80.
2009: Aurelia Noske; Areeg Faggad; Ralph Wirtz; Silvia Darb-Esfahani; Jalid Sehouli; Brigitte Sinn; Omid Niazi; Wilko Weichert; Ann-Christin Buckendahl; Annika Röske; Berit Müller; Manfred Dietel; Carsten Denkert
IMP3 expression in human ovarian cancer is associated with improved survival.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2009;28(3):203-10.
2009: Frank Chih-Kang Chen; G Oskay-Ozcelik; Kai J Bühling; Uta Köpstein; Monika Mentze; Werner Lichtenegger; Jalid Sehouli
Prognostic value of serum and ascites levels of estradiol, FSH, LH and prolactin in ovarian cancer.
Anticancer research 2009;29(5):1575-8.
2009: Areeg Faggad; Silvia Darb-Esfahani; Ralph Wirtz; Brigitte Sinn; Jalid Sehouli; Dominique Könsgen; Hermann Lage; Aurelia Noske; Wilko Weichert; Ann-Christin Buckendahl; Jan Budczies; Berit M Müller; Nasr E Elwali; Manfred Dietel; Carsten Denkert
Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis.
Histopathology 2009;54(6):657-66.
2009: Ignace Vergote; Hilary Calvert; Marek Kania; Christopher Kaiser; Annamaria Hayden Zimmermann; Jalid Sehouli
A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer.
European journal of cancer (Oxford, England : 1990) 2009;45(8):1415-23.
2009: Areeg Faggad; Silvia Darb-Esfahani; Ralph Wirtz; Brigitte Sinn; Jalid Sehouli; Dominique Könsgen; Hermann Lage; Wilko Weichert; Aurelia Noske; Jan Budczies; Berit M Müller; Ann-Christin Buckendahl; Annika Röske; Nasr Eldin Elwali; Manfred Dietel; Carsten Denkert
Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(4):579-88.
2009: Jalid Sehouli; G Oskay-Ozcelik
Current role and future aspects of topotecan in relapsed ovarian cancer.
Current medical research and opinion 2009;25(3):639-51.
2009: Sherko Kuemmel; Anke Thomas; Solveig Landt; Andrea Fuger; Peter Schmid; Monika Kriner; Jens-Uwe Blohmer; Jalid Sehouli; Gerhard Schaller; Werner Lichtenegger; Angela Köninger; Ilka Fuchs
Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer.
Anticancer research 2009;29(2):641-5.
2009: Alexander Mustea; Elena Ioana Braicu; Dominique Koensgen; Shuhui Yuan; Peng-ming Sun; Florin Stamatian; Werner Lichtenegger; Frank Chih-Kang Chen; Radoslav Chekerov; Jalid Sehouli
Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: results from a prospective pilot-study.
Cytokine 2009;45(1):8-11.
2008: Aurelia Noske; Juliane Lena Lindenberg; Silvia Darb-Esfahani; Wilko Weichert; Ann-Christin Buckendahl; Annika Röske; Jalid Sehouli; Manfred Dietel; Carsten Denkert
Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis.
Oncology reports 2008;20(6):1409-17.
2008: Christina Fotopoulou; Ulf Neumann; Christine Klapp; Werner Lichtenegger; Jalid Sehouli
Long-term effects of neovaginal reconstruction with sigmoid loop technique on sexual function and self image in patients with gynecologic malignancies: results of a prospective study.
Gynecologic oncology 2008;111(3):400-6.
2008: Jalid Sehouli; Dominique Koensgen; G Oskay-Ozcelik; Alexander Mustea
New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.
Critical reviews in oncology/hematology 2008;67(3):204-12.
2008: Chie Hee Cho; Peter Wust; Bert Hildebrandt; Rolf Issels; Jalid Sehouli; Thoralf Kerner; Maria Deja; Volker Budach; Johanna Gellermann
Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2008;24(5):399-408.
2008: Dominique Koensgen; Dirk Stengel; Antje Belau; Peter Klare; Guelten Oskay-Oezcelik; Thomas Steck; Oumar Camara; Alexander Mustea; Harald Sommer; Alexandra Coumbos; Thomas Bogenrieder; Werner Lichtenegger; Jalid Sehouli
Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study.
Cancer chemotherapy and pharmacology 2008;62(3):393-400.
2008: Christina Fotopoulou; Jalid Sehouli; Joerg Schefold; Claudia Wolf; Carsten Denkert; Werner Lichtenegger; Wolfgang Henrich
Preoperative transvaginal ultrasound (TVS) in the description of pelvic tumor spread in endometrial cancer: results of a prospective study.
Anticancer research 2008;28(4C):2453-8.
2008: Jalid Sehouli; Dirk Stengel; Guelten Oskay-Oezcelik; Alain G Zeimet; Harald Sommer; Peter Klare; Martina Stauch; Axel Paulenz; Oumar Camara; Elke Keil; Werner Lichtenegger
Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3176-82.
2008: Christina Fotopoulou; Andreas duBois; Alexandros N Karavas; Ralf Trappe; Behnaz Aminossadati; Barbara Schmalfeldt; Jacobus Pfisterer; Jalid Sehouli
Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2683-9.
2008: Nikola Serena Kasprowicz; Christina Fotopoulou; G Oskay-Ozcelik; Khalfaoui Khalid El; Dirk Boehmer; Jalid Sehouli
Brain metastases in relapsed epithelial ovarian cancer after chemotherapy with pegylated liposomal doxorubicin.
Anticancer research 2008;28(3B):1943-6.
2008: Aurelia Noske; Wilko Weichert; Silvia Niesporek; Annika Röske; Ann-Christin Buckendahl; Ines Koch; Jalid Sehouli; Manfred Dietel; Carsten Denkert
Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
Cancer 2008;112(8):1733-43.
2008: Roger von Moos; Beat J K Thuerlimann; Matti Aapro; Daniel Rayson; Karen Harrold; Jalid Sehouli; Florian Scotte; Domenica Lorusso; Reinhard Dummer; Mario Lacouture; Jürgen Lademann; Axel Hauschild
Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts.
European journal of cancer (Oxford, England : 1990) 2008;44(6):781-90.
2008: Alexander Mustea; Cristina Pirvulescu; Dominique Könsgen; Elena Ioana Braicu; S Yuan; Pengming Sun; Werner Lichtenegger; Jalid Sehouli
Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Cytokine 2008;42(1):77-84.
2008: Guelten Oskay-Oezcelik; Dominique Koensgen; Hans-Joachim Hindenburg; Peter Klare; Barbara Schmalfeldt; Werner Lichtenegger; Radoslav Chekerov; Salah-Eddin Al-Batran; Ulf Neumann; Jalid Sehouli
Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO.
Anticancer research 2008;28(2B):1329-34.
2008: Mark Hackbarth; Norbert Haas; Christina Fotopoulou; Werner Lichtenegger; Jalid Sehouli
Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(3):267-73.
2008: Ilka B Fuchs; Joachim W Dudenhausen; Jalid Sehouli; Wolfgang Henrich
Placenta pathology: disorders of placental location, placental implantation and cord insertion.
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2008;29(1):4-17; quiz 18-23.
2008: Lukas A Hefler; Nicole Concin; Gerda Hofstetter; Christian Marth; Alexander Mustea; Jalid Sehouli; Robert Zeillinger; Heinz Leipold; Harald Lass; Christoph Grimm; Clemens B Tempfer; Alexander Reinthaller
Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):710-4.
2008: Jalid Sehouli; Dirk Stengel; Alexander Mustea; Oumar Camara; Elke Keil; Dirk Elling; Peter Ledwon; Bernd Christiansen; Peter Klare; Gerhard Gebauer; Marina Schwarz; Werner Lichtenegger
Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO.
Cancer chemotherapy and pharmacology 2008;61(2):243-50.
2008: S Kummel; H Heidecke; B Brock; C Denkert; J Hecktor; A Koninger; I Becker; Jalid Sehouli; A Thomas; J U Blohmer; W Lichtenegger; Rainer Kimmig
[Imatinib--a possible therapeutic option for cervical carcinoma: results of a preclinical phase I study].
Gynäkologisch-geburtshilfliche Rundschau 2008;48(2):94-100.
2008: Klaus Pietzner; Aurelia Noske; Chie Hee Cho; Felix Kiecker; Jalid Sehouli
Amelanotic metastasis of melanoma mimicking ovarian cancer: a case report and review of the literature.
Anticancer research 2008;28(1B):563-6.
2008: Armin Thelen; Christoph Benckert; Sven Jonas; Enrique Lopez-Hänninen; Jalid Sehouli; Ulf Neumann; Birgit Rudolph; Peter Neuhaus
Liver resection for metastases from breast cancer.
Journal of surgical oncology 2008;97(1):25-9.
2008: R Chekerov; Carsten Denkert; Dirk Boehmer; A Suesse; A Widing; B Ruhmland; A Giese; Alexander Mustea; Werner Lichtenegger; Jalid Sehouli
Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(1):1-7.
2007: Steffen Runz; Sascha Keller; Christian Rupp; Alexander Stoeck; Yasmin Issa; Dominique Koensgen; Alexander Mustea; Jalid Sehouli; Glen Kristiansen; Peter Altevogt
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.
Gynecologic oncology 2007;107(3):563-71.
2007: Wolfgang Henrich; Christina Fotopoulou; Ilka B Fuchs; Claudia Wolf; Annette Schmider; Carsten Denkert; Werner Lichtenegger; Jalid Sehouli
Value of preoperative transvaginal sonography (TVS) in the description of tumor pattern in ovarian cancer patients: results of a prospective study.
Anticancer research 2007;27(6C):4289-94.
2007: Dominique Koensgen; Alexander Mustea; Irina Klaman; Pengming Sun; Menelaos Zafrakas; Werner Lichtenegger; Carsten Denkert; Edgar Dahl; Jalid Sehouli
Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
Gynecologic oncology 2007;107(2):266-73.
2007: Alexander Mustea; Georg Heinze; Jalid Sehouli; Dominique Koensgen; Andrea Wolf; Lilian Gutu; Dumitru Sofroni; Cristina Pirvulescu; Elena Ioana Braicu; Eva Schuster; Robert Zeillinger; Dan Cacsire Castillo-Tong
The -463G/A polymorphism in myeloperoxidase gene and cervical cancer.
Anticancer research 2007;27(3B):1531-5.
2007: Alexander Mustea; Jalid Sehouli; Gerhild Fabjani; Dominique Koensgen; V Möbus; Elena Ioana Braicu; Cristina Pirvulescu; Anke Thomas; Dan Cacsire Castillo-Tong; Robert Zeillinger
Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study.
Anticancer research 2007;27(3B):1527-30.
2007: Uwe Wagner; Andreas du Bois; Jacobus Pfisterer; Jens Huober; Sibylle Loibl; Hans-Joachim Lück; Jalid Sehouli; Martina Gropp; Anne Stähle; Barbara Schmalfeldt; Werner Meier; Christian Jackisch
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6).
Gynecologic oncology 2007;105(1):132-7.
2007: Ilka B Fuchs; N Vorsteher; Helmut Bühler; K Evers; Jalid Sehouli; Gerhard Schaller; Sherko Kümmel
The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
Anticancer research 2007;27(2):959-63.
2007: G Oskay-Ozcelik; Walter Lehmacher; Dominique Könsgen; Hildegard Christ; M Kaufmann; Werner Lichtenegger; D D; D Wallwiener; F Overkamp; K Diedrich; Gunter von Minckwitz; K Höffken; S Seeber; R Mirz; Jalid Sehouli
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):479-84.
2007: Elena Ioana Braicu; Alexander Mustea; Mohammad R Toliat; Cristina Pirvulescu; Dominique Könsgen; Pengming Sun; Peter Nürnberg; Werner Lichtenegger; Jalid Sehouli
Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients.
Gynecologic oncology 2007;104(3):680-5.
2007: Christian Marth; Joan L Walker; Richard R Barakat; Antonio Casado; Angiolo Gadducci; Brigitte Miller; Franco Odicino; Eric Pujade-Lauraine; Jalid Sehouli; Claes Tropé; Lari Wenzel; Alain G Zeimet
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer.
Cancer 2007;109(4):645-9.
2007: Aurelia Noske; Alexander Kaszubiak; Wilko Weichert; Christine Sers; Silvia Niesporek; Ines Koch; Birgit Schaefer; Jalid Sehouli; Manfred Dietel; Hermann Lage; Carsten Denkert
Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.
Cancer letters 2007;246(1-2):190-200.
2007: Peng-ming Sun; Li-hui Wei; Mei-Yu Luo; Guang Liu; Jiang-Liu Wang; Alexander Mustea; Dominique Könsgen; Werner Lichtenegger; Jalid Sehouli
The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
European journal of obstetrics, gynecology, and reproductive biology 2007;130(2):249-57.
2007: Ivo Meinhold-Heerlein; Dirk Bauerschlag; Yingyao Zhou; Lisa M Sapinoso; Keith Ching; Henry F Frierson; Karen Bräutigam; Jalid Sehouli; Elmar Stickeler; Dominique Könsgen; Felix Hilpert; Constantin S von Kaisenberg; Jacobus Pfisterer; Thomas Bauknecht; Walter Jonat; Norbert Arnold; Garret M Hampton
An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 1):458-66.
2007: Silvia Niesporek; Wilko Weichert; Brigitte Sinn; A Röske; Aurelia Noske; Ann-Christin Buckendahl; R Wirtz; Jalid Sehouli; Dominique Koensgen; Manfred Dietel; Carsten Denkert
[NF-kappaB subunit p65/RelA expression in ovarian carcinoma: prognostic impact and link to COX-2 overexpression].
Verhandlungen der Deutschen Gesellschaft für Pathologie 2007;91():243-9.
2006: Peter Wust; Uwe Gneveckow; Manfred Johannsen; Dirk Böhmer; Thomas Henkel; Frank Kahmann; Jalid Sehouli; Roland Felix; Jens Ricke; Andreas Jordan
Magnetic nanoparticles for interstitial thermotherapy--feasibility, tolerance and achieved temperatures.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2006;22(8):673-85.
2006: Philipp Harter; Andreas du Bois; Maik Hahmann; Annette Hasenburg; Alexander Burges; Sibylle Loibl; Martina Gropp; Jens Huober; Daniel Fink; Willibald Schröder; Karsten Muenstedt; Barbara Schmalfeldt; Guenter Emons; Jacobus Pfisterer; Kerstin Wollschlaeger; Hans-Gerd Meerpohl; Georg-Peter Breitbach; Berno Tanner; Jalid Sehouli
Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
Annals of surgical oncology 2006;13(12):1702-10.
2006: Carsten Denkert; Jan Budczies; Tobias Kind; Wilko Weichert; Peter Tablack; Jalid Sehouli; Silvia Niesporek; Dominique Könsgen; Manfred Dietel; Oliver Fiehn
Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.
Cancer research 2006;66(22):10795-804.
2006: Jacobus Pfisterer; Andreas du Bois; Jalid Sehouli; Sibylle Loibl; S Reinartz; Alexander Reuss; U Canzler; A Belau; Christian Jackisch; Rainer Kimmig; Kerstin Wollschlaeger; Volker Heilmann; Felix Hilpert
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1568-77.
2006: Berno Tanner; Dirk Hasenclever; Katja Stern; Wiebke Schormann; Martin Bezler; Matthias Hermes; Marc Brulport; Alexander Bauer; Ilka B Schiffer; Susanne Gebhard; Markus Schmidt; Eric Steiner; Jalid Sehouli; Jeanett Edelmann; Jürgen Läuter; Rüdiger Lessig; Krishnamurthi Kannan; Axel Ullrich; Jan G Hengstler
ErbB-3 predicts survival in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4317-23.
2006: Andreas du Bois; Barbara Schmalfeldt; Werner Meier; Jalid Sehouli; Jacobus Pfisterer
Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(5):1756-60.
2006: Andreas du Bois; Barbara Schmalfeldt; W Meier; Jalid Sehouli; Jacobus Pfisterer
[Ovarian cancer -- can peritoneal therapy be regarded as new standard?].
Zentralblatt für Gynäkologie 2006;128(4):202-6.
2006: Salah-Eddin Al-Batran; J Bischoff; Gunter von Minckwitz; Akin Atmaca; Ulrich Kleeberg; I Meuthen; G Morack; W Lerbs; Detlef Hecker; Jalid Sehouli; Alexander Knuth; Elke Jager
The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial.
British journal of cancer 2006;94(11):1615-20.
2006: Jalid Sehouli; G Oskay-Ozcelik; J Kühne; Dirk Stengel; Hans-Joachim Hindenburg; Peter Klare; Georg Heinrich; Barbara Schmalfeldt; H Mertens; Oumar Camara; Werner Lichtenegger
Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):957-61.
2006: Jalid Sehouli; Jens H Stupin; Ulrike Schlieper; Sherko Kuemmel; Wolfgang Henrich; Carsten Denkert; Manfred Dietel; Werner Lichtenegger
Actinomycotic inflammatory disease and misdiagnosis of ovarian cancer. A case report.
Anticancer research 2006;26(2C):1727-31.
2006: Sherko Kümmel; Holm Eggemann; Diana Lüftner; Anke Thomas; Sophia Jeschke; Nadine Zerfel; Volker Heilmann; Günter Emons; Tobias Zeiser; Kurt Ulm; Michael Kobl; Susanne Korlach; Peter Schmid; Jalid Sehouli; Dirk Elling; Jens-Uwe Blohmer
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes.
Anticancer research 2006;26(2C):1719-26.
2006: Alexander Mustea; Dominique Könsgen; Elena Ioana Braicu; Cristina Pirvulescu; Pengming Sun; Dumitru Sofroni; Werner Lichtenegger; Jalid Sehouli
Expression of IL-10 in patients with ovarian carcinoma.
Anticancer research 2006;26(2C):1715-8.
2006: Sherko Kümmel; Anke Thomas; Sophia Jeschke; Maik Hauschild; Jalid Sehouli; Werner Lichtenegger; Jens-Uwe Blohmer
Postoperative therapy modalities for cervical carcinoma.
Anticancer research 2006;26(2C):1707-13.
2006: Pengming Sun; Lihui Wei; Carsten Denkert; Werner Lichtenegger; Jalid Sehouli
The orphan nuclear receptors, estrogen receptor-related receptors: their role as new biomarkers in gynecological cancer.
Anticancer research 2006;26(2C):1699-706.
2006: Dominique Koensgen; Alexander Mustea; Carsten Denkert; Peng-ming Sun; Werner Lichtenegger; Jalid Sehouli
Overexpression of the plasminogen activator inhibitor type-1 in epithelial ovarian cancer.
Anticancer research 2006;26(2C):1683-9.
2006: Barbara Schmalfeldt; Andreas du Bois; Alexander Burges; G Emons; D Fink; Martina Gropp; Annette Hasenburg; W Jäger; Rainer Kimmig; Marion Kiechle; Friedrich Kommoss; R Kreienberg; W Kuhn; Hans-Joachim Lück; Werner Meier; K Münstedt; O Ortmann; Jacobus Pfisterer; B Richter; Ingo B Runnebaum; W Schröder; Jalid Sehouli; B Tanner; Uwe Wagner; J Weis
[Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO].
Zentralblatt für Gynäkologie 2006;128(1):11-7.
2006: Peng-ming Sun; Min Gao; Li-hui Wei; Alexander Mustea; Jian-liu Wang; Dominique Könsgen; Werner Lichtenegger; Jalid Sehouli
An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cells.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():564-8.
2006: Salah-Eddin Al-Batran; Hans-Gerd Meerpohl; Gunter von Minckwitz; Akin Atmaca; Ulrich Kleeberg; Nadia Harbeck; Werner Lerbs; Detlef Hecker; Jalid Sehouli; Alexander Knuth; Elke Jager
Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer.
Oncology 2006;70(2):141-6.
2006: Radoslav Chekerov; Irina Klaman; Menelaos Zafrakas; Dominique Könsgen; Alexander Mustea; Beate Petschke; Werner Lichtenegger; Jalid Sehouli; Edgar Dahl
Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.
Neoplasia (New York, N.Y.) 2006;8(1):38-45.
2005: Diana Lüftner; Diane Pollmann; Steffi Schildhauer; Jalid Sehouli; Kurt Possinger
Perspectives of immunotherapy in metastatic breast cancer.
Anticancer research 2005;25(6C):4599-604.
2005: Gerrit Mohrmann; Jan G Hengstler; Thomas G Hofmann; Sabine Endele; Brendan Lee; Christiane Stelzer; Bernhard Zabel; Juergen Brieger; Dirk Hasenclever; Berno Tanner; Jens Sagemueller; Jalid Sehouli; Hans Will; Andreas Winterpacht
SPOC1, a novel PHD-finger protein: association with residual disease and survival in ovarian cancer.
International journal of cancer. Journal international du cancer 2005;116(4):547-54.
2005: Peng-ming Sun; Li-hui Wei; Jalid Sehouli; Carsten Denkert; Dan Zhao; Min Gao; Xiu-li Sun; Werner Litchtenegger
[Role of estrogen receptor-related receptors alpha, beta and gamma in ovarian cancer cells].
Zhonghua fu chan ke za zhi 2005;40(8):544-8.
2005: Ute Jacobi; E Waibler; P Schulze; Jalid Sehouli; G Oskay-Ozcelik; Tobias Schmook; W Sterry; J Lademann
Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1210-1.
2005: Dominique Könsgen; Alexander Mustea; Werner Lichtenegger; Jalid Sehouli
[Role of PAI-1 in gynaecological malignancies].
Zentralblatt für Gynäkologie 2005;127(3):125-31.
2005: Pengming Sun; Jalid Sehouli; Carsten Denkert; Alexander Mustea; Dominique Könsgen; Ines Koch; Lihui Wei; Werner Lichtenegger
Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells.
Journal of molecular medicine (Berlin, Germany) 2005;83(6):457-67.
2005: Silvia Niesporek; Carsten Denkert; Wilko Weichert; Martin Köbel; Aurelia Noske; Jalid Sehouli; jack w singer; Manfred Dietel; Steffen Hauptmann
Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis.
British journal of cancer 2005;92(9):1729-36.
2005: Jalid Sehouli
Review of gemcitabine-based combinations for platinum-resistant ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15 Suppl 1():23-30.
2005: Kai J Buhling; Thomas Harder; Jalid Sehouli; Jennifer Nanz; Andreas Plagemann; Joachim W Dudenhausen
Independent association between leptin and blood pressure during third trimester in normal and gestational diabetic pregnancies.
European journal of obstetrics, gynecology, and reproductive biology 2005;119(2):180-4.
2005: Ivo Meinhold-Heerlein; Dirk Bauerschlag; Felix Hilpert; Petre Dimitrov; Lisa M Sapinoso; Marzenna Orlowska-Volk; Thomas Bauknecht; Tjoung-Won Park; Walter Jonat; Anja Jacobsen; Jalid Sehouli; Jutta Luttges; Maryla Krajewski; Stan Krajewski; John C Reed; Norbert Arnold; Garret M Hampton
Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.
Oncogene 2005;24(6):1053-65.
2005: Florian Schweigert; Jalid Sehouli
Transthyretin, a biomarker for nutritional status and ovarian cancer.
Cancer research 2005;65(3):1114; author reply 1114.
2005: Beate Gericke; Jens Raila; Jalid Sehouli; Sophie Haebel; Dominique Könsgen; Alexander Mustea; Florian Schweigert
Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.
BMC cancer 2005;5():133.
2005: Dirk Stengel; Kai Bauwens; Jalid Sehouli; Grit Rademacher; Sven Mutze; Axel Ekkernkamp; F Porzsolt
Emergency ultrasound-based algorithms for diagnosing blunt abdominal trauma.
Cochrane database of systematic reviews (Online) 2005;(2):CD004446.
2005: Jalid Sehouli; Julia Kostromitskaia; Dirk Stengel; Andreas du Bois
Why institutions do not participate in ovarian cancer trials -- results from a survey in Germany.
Onkologie 2005;28(1):13-7.
2004: Jalid Sehouli; Alexander Mustea; Dominique Könsgen; Werner Lichtenegger
[Conventional and experimental prognostic factors in ovarian cancer].
Zentralblatt für Gynäkologie 2004;126(5):315-22.
2004: Jalid Sehouli; Frank S Drescher; Alexander Mustea; Dirk Elling; Wolfgang Friedmann; Wolfgang Kühn; Margit Nehmzow; Firu Opri; Peter Klare; Mantred Dietel; Werner Lichtenegger
Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.
Anticancer research 2004;24(2C):1223-9.
2004: Jalid Sehouli; Dirk Stengel; Gülten Oskay; Jens-Uwe Blohmer; Sabine Stienen; Werner Lichtenegger
Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinum.
Onkologie 2004;27(1):58-64.
2004: Florian Schweigert; Jens Raila; Jalid Sehouli; Ulrich Buscher
Accumulation of selected carotenoids, alpha-tocopherol and retinol in human ovarian carcinoma ascitic fluid.
Annals of nutrition & metabolism 2004;48(4):241-5.
2004: Carsten Denkert; Wilko Weichert; Sören Pest; Ines Koch; Dirk Licht; Martin Köbel; Angela Reles; Jalid Sehouli; Manfred Dietel; Steffen Hauptmann
Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.
Cancer research 2004;64(1):189-95.
2003: Jalid Sehouli; Alexander Mustea; Dominique Koensgen; Werner Lichtenegger
Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(11 Pt 1):1205-8.
2003: Jalid Sehouli; Alexander Mustea; Dominique Koensgen; F C-K Chen; Werner Lichtenegger
Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(10):1501-4.
2003: Jalid Sehouli; Dominique Könsgen; Robert Nimpsch; Dirk Stengel; Gülten Oskay; Alexander Mustea; Joachim Oertel; Werner Lichtenegger
Prognostic significance of epithelial cells in the blood of patients with gynaecological malignancies.
Anticancer research 2003;23(5b):4133-40.
2003: Jalid Sehouli; Dirk Stengel; Gülten Oskay; Jens-Uwe Blohmer; Sabine Stienen; Werner Lichtenegger
A new therapeutical approach: topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy with paclitaxel and platinum.
The journal of obstetrics and gynaecology research 2003;29(3):123-31.
2003: Jens Ricke; Jalid Sehouli; Constanze Hach; Enrique Lopez Hänninen; Werner Lichtenegger; Roland Felix
Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer.
European radiology 2003;13(5):943-9.
2003: Jalid Sehouli; Oumar Camara; Dirk Stengel; Günter Köhler; Werner Lichtenegger
[Multi-institutional survey on the value of lymphadenectomy in endometrial carcinoma in Germany].
Gynäkologisch-geburtshilfliche Rundschau 2003;43(2):104-10.
2003: Jalid Sehouli; Dominique Könsgen; Alexander Mustea; G Oskay-Ozcelik; I Katsares; H Weidemann; Werner Lichtenegger
["IMO"--intraoperative mapping of ovarian cancer].
Zentralblatt für Gynäkologie 2003;125(3-4):129-35.
2003: Jalid Sehouli; Zera Akdogan; Thomas Heinze; Dominique Könsgen; Dirk Stengel; Alexander Mustea; Werner Lichtenegger
Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study.
Anticancer research 2003;23(2A):1115-8.
2003: Alexander Mustea; Jalid Sehouli; Dominique Könsgen; Dirk Stengel; Dumitru Sofroni; Werner Lichtenegger
Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer.
Anticancer research 2003;23(2A):1099-102.
2003: Jalid Sehouli; Dominique Könsgen; Robert Nimpsch; Gülten Oskay; Dirk Stengel; Joachim Oertel; Werner Lichtenegger; Alexander Mustea
Detection of epithelial carcinoma cells in the blood of patients with gynaecological malignancies.
Anticancer research 2003;23(2A):1093-7.
2003: Dirk Stengel; Kai Bauwens; Jalid Sehouli; Axel Ekkernkamp; F Porzsolt
A likelihood ratio approach to meta-analysis of diagnostic studies.
Journal of medical screening 2003;10(1):47-51.
2002: Jalid Sehouli; Alexander Mustea; Dominique Könsgen; Ioanna Katsares; Werner Lichtenegger
Polymorphism of IL-1 receptor antagonist gene: role in cancer.
Anticancer research 2002;22(6A):3421-4.
2002: Jalid Sehouli; Dirk Stengel; Gülten Oskay; Oumar Camara; Hans-Joachim Hindenburg; Peter Klare; Jens-Uwe Blohmer; Georg Heinrich; Dirk Elling; P Ledwon; Werner Lichtenegger
A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(11):1749-55.
2002: Jalid Sehouli; Alexander Mustea
Interleukin-1 receptor antagonist gene polymorphism and cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(11):1535-6.
2002: Jalid Sehouli; Dirk Stengel; Dirk Elling; Olaf Ortmann; Jens-Uwe Blohmer; Hanno Riess; Werner Lichtenegger
First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: a phase I study.
Gynecologic oncology 2002;85(2):321-6.
2001: Dirk Stengel; Kai Bauwens; Jalid Sehouli; Axel Ekkernkamp; F Porzsolt
Systematic review and meta-analysis of antibiotic therapy for bone and joint infections.
The Lancet infectious diseases 2001;1(3):175-88.
2001: Dirk Stengel; Matthias Orth; R Tauber; Jalid Sehouli; S Hentsch; H K Thielemann; Reinhold-Alexander Laun; Axel Ekkernkamp
Shed L-selectin (sCD62L) load in trauma patients.
The Journal of surgical research 2001;99(2):321-7.
2001: Dirk Stengel; Kai Bauwens; Jalid Sehouli; J Nantke; Axel Ekkernkamp
Discriminatory power of 3.5 MHz convex and 7.5 MHz linear ultrasound probes for the imaging of traumatic splenic lesions: a feasibility study.
The Journal of trauma 2001;51(1):37-43.
2001: Dirk Stengel; Kai Bauwens; Jalid Sehouli; F Porzsolt; Grit Rademacher; Sven Mutze; Axel Ekkernkamp
Systematic review and meta-analysis of emergency ultrasonography for blunt abdominal trauma.
The British journal of surgery 2001;88(7):901-12.
2001: Carsten Oberhoff; Dirk G Kieback; R Würstlein; H Deertz; Jalid Sehouli; C van Soest; Jörn Hilfrich; M Mesrogli; G von Minckwitz; H J Staab; Adolf E Schindler
Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study.
Onkologie 2001;24(3):256-60.
2001: Jens-Uwe Blohmer; Stefan Paepke; Dirk Böhmer; B Ernhardt; Jalid Sehouli; Dirk Elling; Werner Lichtenegger
[Adjuvant chemotherapy of cervix carcinoma--results of a phase II study].
Zentralblatt für Gynäkologie 2001;123(5):286-91.
2001: Jalid Sehouli; Dirk Stengel; J Hindenburg; Oumar Camara; F Porzsolt; Werner Lichtenegger
[Challenge of evidence-based medicine: sense and non-sense of diagnostic tests in gynecology].
Zentralblatt für Gynäkologie 2001;123(3):127-31.
2000: Jalid Sehouli
How frequently do female patients with gynecological cancers use unconventional cancer therapies?
Gynecologic oncology 2000;79(2):336-7.
2000: Jalid Sehouli; Olaf Kopetsch; J Ricke; E Buchmann; D Stengel; H Riess; H Weidemann; F Schäper; W Freiesleben; Werner Lichtenegger
Primary mucinous adenocarcinoma of the appendix: a rare entity in the differential diagnosis of ovarian cancer.
The journal of obstetrics and gynaecology research 2000;26(5):333-9.
1999: J Ricke; Jalid Sehouli; N Hosten; C Stroszczynski; H Amthauer; J Rieger; E Buchmann; R Felix
[Fat-saturated, contrast-enhanced spin-echo sequences in the magnetic resonance tomographic diagnosis of peritoneal carcinosis].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1999;171(6):461-7.
1998: Werner Lichtenegger; Jalid Sehouli; E Buchmann; C Karajanev; H Weidemann
Operative results after primary and secondary debulking-operations in advanced ovarian cancer (AOC).
The journal of obstetrics and gynaecology research 1998;24(6):447-51.
1998: Matthias David; Jalid Sehouli; S Plischek; H Halle; Werner Lichtenegger
[Nitroglycerin for intraoperative uterus relaxation in cesarean section. Results of a randomized clinical study].
Zeitschrift für Geburtshilfe und Neonatologie 1998;202(4):168-71.
1997: Jalid Sehouli; D Stengel; H Schauwecker
[Benign symmetrical lipomatosis. A therapeutic dilemma?].
Langenbecks Archiv für Chirurgie 1997;382(5):271-3.